Andrew Callos

EVP, Chief Commercial Officer

Andrew Callos (EVP, Chief Commercial Officer) filed 18 Form 4 reports in the trailing twelve months (0 purchases, 18 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $3.5M of CYTK (52,486 sh × $65.95, as filed), executed Dec 5 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 18 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$15.7M

shares × price, as filed

Last traded

Aug 31

Filed Aug 31

Median ADV $207.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $18.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 18 filings

Sector per market data · by filing · past 12 months

Most traded names

CYTK

Cytokinetics, Incorporated CYTK · 0 buys · 25 sells 25 filings

Recent filings

CYTKSALE Cytokinetics, Incorporated View filing → $702K
10,000 sh × $70.24
Exec Aug 31
Filed Aug 31 · 4:57 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $1.1M
14,000 sh × $79.88
Exec Jul 30
Filed Jul 30 · 4:26 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $1.3M
15,000 sh × $85.80
Exec Jul 1
Filed Jul 2 · 5:19 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $1.1M
15,000 sh × $74.08
Exec Jun 1
Filed Jun 1 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $875K
11,333 sh × $77.25
Exec May 5
Filed May 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $1.0M
15,857 sh × $65.00
Exec May 1
Filed May 4 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $949K
15,000 sh × $63.26
Exec Apr 30
Filed Apr 30 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $492K
7,449 sh × $66.02
Exec Apr 15
Filed Apr 15 · 5:30 PM ET More filings →